ArticlePharmaceuticals (Basel, Switzerland)2021

Analysis of the Regulatory Science Applied to a Single Portfolio of Eight Biosimilar Product Approvals by Four Key Regulatory Authorities.

Beverly Ingram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.